- Home
- PDO vs BCRX Comparison
PDO vs BCRX Comparison
Compare PDO & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDO | BCRX |
|---|---|---|
| Founded | 2020 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PDO | BCRX |
|---|---|---|
| Price | $11.80 | $8.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $20.55 |
| AVG Volume (30 Days) | 892.7K | ★ 4.7M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | ★ 11.80% | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.51 | $6.23 |
| 52 Week High | $14.20 | $11.22 |
Technical Indicators
Market Signals| Indicator | PDO | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 51.51 |
| Support Level | $11.51 | $8.09 |
| Resistance Level | $13.23 | $8.60 |
| Average True Range (ATR) | 0.19 | 0.28 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 41.78 | 73.82 |
Price Performance
Historical ComparisonAbout PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary objective is to generate current income, with capital appreciation as a secondary objective. It employs a flexible, multi-sector investment strategy across credit markets, investing in a wide range of income-producing debt securities. The fund actively adjusts allocations to capitalize on opportunities across different economic cycles and market conditions.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.